UCLA’s Dr. Manish Butte will head a group investigating immune responses to the disease, which is caused by fungal spores in soil.
Health + Behavior
Dr. Haig Aintablian, who recently completed his residency in emergency medicine at UCLA, is the program’s inaugural fellow.
Dr. Timothy Fong, co-director of the UCLA Gambling Studies Program, shares insight into how something “fun” can become a devastating addiction for some people.
Research brief: Six months after the shot, nearly 96% of study participants in North Kivu Province still had antibodies in their blood.
A gift from Dr. Bronwyn Bateman will establish a new center at the UCLA Stein Eye Institute.
De Antonio, a clinical psychiatry professor at the Semel Institute for Neuroscience and Human Behavior at UCLA, died Dec. 31, after an extended illness.
The device assesses cortisol levels found in sweat accurately, noninvasively and in real time.
The findings could improve doctors’ ability to offer truly personalized cancer therapy.
Heumann will be joined by Andy Imparato and Vivian Haun, both of Disability Rights California, on Feb. 10 at 4 p.m.
A UCLA study finds that Black and Latino Californians have the lowest rates of employer-based insurance across all groups.
Research brief: Additional services to monitor the drug’s potential side effects account for nearly 20% of its total costs, a UCLA-led study shows.
The institute will collaborate with a community of chefs and scholars in pursuit of a healthier population and planet.
While the situation improved, economically disadvantaged patients were far less likely to return to using services at normal, pre-pandemic levels.
UCLA epidemiologist Robert Kim-Farley reflects on how the U.S. has coped with the pandemic.
The UCLA-led analysis, the largest to date on COVID-19 and breast milk, examined samples from 110 lactating women.
UCLA’s new analysis will help guide Medi-Cal as it expands coordinated care to all eligible participants in the state.
The meeting addressed topics ranging from how to get free masks to the factors under consideration for returning to in-person work and learning.
A UCLA study suggests that new small-molecule drugs that inhibit a protein called ATR could be used in combination with interferon “amplification.”
The study, which used mice, could point toward a method for clearing the virus from people who would otherwise depend on medication.
The substance, Tg6F, contains anti-inflammatory and antioxidant peptides.
With 85% of students surveyed reporting “speed-watching,” UCLA psychology researchers designed experiments to gauge their comprehension.
The UCLA-led research also indicates that the primary culprit in smokers’ increased risk is not nicotine but other chemicals in tobacco smoke.
After more than two years, Marley Gaskins, the first child to receive the innovative treatment for LAD-1, remains disease-free.
Professors continued helping us better understand our world with their research, students kept excelling and UCLA showed how it helps make Los Angeles a world-class city.
Meet the new director of the UCLA Broad Stem Cell Research Center.